1rvm: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Theoretical_model}} | {{Theoretical_model}} | ||
[[Image:1rvm.png|left|200px]] | [[Image:1rvm.png|left|200px]] | ||
{{STRUCTURE_1rvm| PDB=1rvm | SCENE= }} | {{STRUCTURE_1rvm| PDB=1rvm | SCENE= }} | ||
===USING NEVIRAPINE ANALOGS AS STRUCTURAL PROBES TO MODEL THEIR BINDING SITE ON HIV-1 REVERSE TRANSCRIPTASE=== | ===USING NEVIRAPINE ANALOGS AS STRUCTURAL PROBES TO MODEL THEIR BINDING SITE ON HIV-1 REVERSE TRANSCRIPTASE=== | ||
{{ABSTRACT_PUBMED_8648604}} | {{ABSTRACT_PUBMED_8648604}} | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:008648604</ref><references group="xtra"/> | ||
[[Category: Gussio, R]] | [[Category: Gussio, R]] | ||
[[Category: Pattabiraman, N]] | [[Category: Pattabiraman, N]] | ||
Revision as of 09:13, 21 October 2012
USING NEVIRAPINE ANALOGS AS STRUCTURAL PROBES TO MODEL THEIR BINDING SITE ON HIV-1 REVERSE TRANSCRIPTASE
Template:ABSTRACT PUBMED 8648604
Reference
- Gussio R, Pattabiraman N, Zaharevitz DW, Kellogg GE, Topol IA, Rice WG, Schaeffer CA, Erickson JW, Burt SK. All-atom models for the non-nucleoside binding site of HIV-1 reverse transcriptase complexed with inhibitors: a 3D QSAR approach. J Med Chem. 1996 Apr 12;39(8):1645-50. PMID:8648604 doi:10.1021/jm9508088
